Mifepristone and Misoprostol Tablets | Abortion Pill Pack

Mifepristone and Misoprostol Tablets are a combination of medicines used for medication abortion under appropriate medical guidance. This combination is commonly referred to internationally as a medication abortion pack, abortion pill pack or medical abortion tablets.

Mifepristone blocks progesterone, a hormone required to sustain pregnancy. Misoprostol causes uterine contractions and helps the uterus expel pregnancy tissue.

The combination is authorized for use within specified pregnancy-duration limits, which vary according to the product and jurisdiction. It should be used in accordance with the applicable product information and guidance from a qualified healthcare professional.

Product Information

Product Name

Mifepristone and Misoprostol Tablets

Active Ingredients

Mifepristone and misoprostol

Common Mifepristone Strength

200 mg per tablet

Common Misoprostol Strength

200 micrograms per tablet

Common Pack Presentation

One mifepristone tablet and four misoprostol tablets

Dosage Form

Oral tablets, with misoprostol administration depending on the approved regimen

Therapeutic Category

Medication abortion

Primary Indication

Medical termination of an intrauterine pregnancy within the approved gestational limit

Common International Terms

Medication abortion pack, abortion pill pack, medical abortion tablets

Reference Brands

Mifegymiso and MS-2 Step, depending on the country

Pack Size

Verify actual packaging and tablet count

Prescription Requirement

Subject to local regulations

Generic Combination Pack vs. Branded Products

Mifepristone and misoprostol are the active ingredients used in established medication abortion products. Brand names differ between countries; examples include Mifegymiso in Canada and MS-2 Step in Australia.

A pack containing the same active ingredients does not automatically qualify as an authorized generic or interchangeable product. Confirm the manufacturer's identity, tablet strengths, formulation, quality documentation and regulatory status in the destination country before describing a product as a generic equivalent.

Ordering and Availability

For information about Mifepristone and Misoprostol pack pricing, pack contents and availability, contact the supplier to verify the exact formulation, manufacturer, packaging and current stock.

Approval, prescription requirements, eligible suppliers and import restrictions vary by country. Confirm local authorization and applicable rules before listing or supplying the product.

Mifepristone and misoprostol may be used together for:

• Medication Abortion: Ending an intrauterine pregnancy within the gestational limits specified by the applicable product authorization.
• Non-surgical Treatment: Providing a medication-based option that does not require an abortion procedure in an operating room.
• Clinically Supervised Care: Supporting a treatment pathway with access to assessment, follow-up and additional care when needed.

Eligibility depends on gestational age, medical history, contraindications and the approved local regimen. These medicines are not a treatment for ectopic pregnancy.

Use Mifepristone and Misoprostol Tablets only according to the prescription, official product leaflet and guidance of a qualified healthcare professional.

The medicines are taken in a specified sequence. The dose, timing, administration route and follow-up requirements depend on the authorized product and treatment protocol.

Do not substitute tablets, change the prescribed sequence or use products with unverified strengths. Follow-up is important to confirm that the treatment has been completed successfully and to determine whether additional care is required.

Storage Instructions

Store each medicine according to its own manufacturer's instructions. Keep tablets in their original packaging where appropriate and protect them from moisture, excessive heat and unsuitable storage conditions.

Do not use expired tablets, damaged packaging or products with uncertain storage history. Keep all medicines out of the reach of children.

Common effects may include:

• Abdominal cramps and pain
• Vaginal bleeding
• Nausea or vomiting
• Diarrhoea
• Headache or dizziness
• Chills or temporary fever

Bleeding and cramping are expected effects of the treatment, but complications can occur.

Seek urgent medical care for very heavy bleeding, severe or persistent abdominal pain, fainting, difficulty breathing, persistent fever or feeling seriously unwell. Urgent assessment is also important if pregnancy symptoms persist or there is concern that the treatment has not worked.

Before treatment, a qualified healthcare professional should assess pregnancy duration, medical history, relevant contraindications and the possibility of ectopic pregnancy.

Important precautions include:

• Ectopic pregnancy: Mifepristone and misoprostol do not treat a pregnancy located outside the uterus.
• Bleeding disorders: A history of bleeding problems or use of anticoagulant medicines may affect suitability.
• Adrenal conditions and corticosteroids: Chronic adrenal failure and long-term systemic corticosteroid treatment are important considerations for mifepristone-containing regimens.
• Intrauterine devices: An IUD may need to be removed before treatment, according to the applicable clinical protocol.
• Treatment follow-up: Assessment is needed to confirm completion and identify complications or ongoing pregnancy.
• Emergency access: Patients should understand how to obtain urgent medical care if serious symptoms develop.

This list is not exhaustive. Consult the official product information for the full contraindications, warnings and precautions.